Cartia XT Diltiazem Hydrochloride Capsules Recalled for Incorrect Expiration Date
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg due to an incorrect expiration date printed on the label. The affected lot was distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II labeling error involving incorrect expiration date information. The source text does not report any hospitalizations, illnesses, or injuries, and this is a labeling/documentation issue rather than a manufacturing defect, making it a moderate-severity precautionary recall.
Plain-English summary
Teva Pharmaceuticals USA is recalling Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, 90-capsule bottles, due to an incorrect expiration date on the product label. The affected lot is Lot # 100023805, labeled with an expiration date of 05/2023.
The recalled product was distributed nationwide in the United States. A total of 32,316 bottles are affected by this recall.
Patients currently taking this medication from the affected lot should contact their healthcare provider or pharmacist for guidance. Consumers should not use the affected product and should return it to the pharmacy where it was dispensed or contact the manufacturer for instructions on how to proceed.
The recalled product
- Product
- CARTIA (DILTIAZEM HYDROCHLORIDE)
- Brand
- CARTIA
- Manufacturer
- Teva Pharmaceuticals USA
- Affected units
- 32,316
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 100023805
- Exp. Date 05/2023
UPCs (4)
- 0362037598906
- 0362037599903
- 0362037597909
- 0362037600906
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · mis labeling
See all →- HighBetterballen Foods Frozen Meat and Poultry Products Alerted for Undeclared Allergens
USDA FSIS · 2026-11-06
- HighEl Ruisenor De Mexico Recalls Dried Peaches for Undeclared Sulfites
FDA (Food) · 2026-10-28
- ModerateEl Ruisenor De Mexico Recalls Ground Shrimp for Undeclared Allergen
FDA (Food) · 2026-10-28
- ModerateEl Ruisenor De Mexico Recalls Natural Sesame Seeds for Undeclared Allergen
FDA (Food) · 2026-10-28
- ModerateEl Ruisenor De Mexico Recalls Almond Flour for Undeclared Allergen
FDA (Food) · 2026-10-28
Similar recalls
- LowTeva Recalls Matzim LA Tablets Due to GMP Deviation
FDA (Drugs) · 2019-10-16
- ModerateActavis Recalls Cartia XT Capsules Due to Aluminum Residue on Exterior
FDA (Drugs) · 2015-04-22
- HighDiltiazem Hydrochloride Capsules Recalled Due to N-Nitroso Impurity Above Limits
FDA (Drugs) · 2024-12-11
- HighDiltiazem Hydrochloride extended-release capsules recalled due to failed quality specifications
FDA (Drugs) · 2023-02-08
- HighPrescription Drug Matzim LA Extended-Release Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-08-10
- LowTeva Recalls Irbesartan and Hydrochlorothiazide Tablets Due to Labeling Errors
FDA (Drugs) · 2015-12-23